Chordia Therapeutics, Inc.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 2017-01-01
- Employees
- 21
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Phase 1
Recruiting
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic Syndromes
- Interventions
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2025-09-22
- Lead Sponsor
- Chordia Therapeutics, Inc.
- Target Recruit Count
- 225
- Registration Number
- NCT05732103
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸Fred Hutchinson Cancer Center, Seattle, Washington, United States
🇺🇸Mayo Clinic Arizona, Phoenix, Arizona, United States
News
No news found